scholarly journals A case of systemic lupus erythematosus demonstrating basal ganglia calcifications, coronary stenosis and selective IgA deficiency.

1986 ◽  
Vol 75 (1) ◽  
pp. 83-88 ◽  
Author(s):  
Mitsuo MAEDA ◽  
Yoshiaki KITAMURA ◽  
Mitsuko TAKATA ◽  
Yasushi NAKAMURA ◽  
Shogo MASUDA ◽  
...  
2015 ◽  
Vol 67 (6) ◽  
pp. 1592-1597 ◽  
Author(s):  
Lien Van Eyck ◽  
Lien De Somer ◽  
Diana Pombal ◽  
Simon Bornschein ◽  
Glynis Frans ◽  
...  

1986 ◽  
Vol 9 (3) ◽  
pp. 224-229
Author(s):  
Taijiro Ishiyama ◽  
Sotaro Abe ◽  
Seiichi Horie ◽  
Naoki Sugaya ◽  
Yoshihisa Wakabayashi ◽  
...  

1992 ◽  
Vol 15 (1) ◽  
pp. 67-74
Author(s):  
Seiji Takeda ◽  
Keisuke Onuki ◽  
Shin-ichi Tohara ◽  
Taketoshi Kodama ◽  
Kenji Kono

2020 ◽  
Vol 66 (6) ◽  
pp. 752-756
Author(s):  
Gustavo Felício Alexandroni Linzmeyer ◽  
Fabiane Karen Miyake ◽  
Thiago Alberto F. C. Gomes Dos Santos ◽  
Thelma L Skare

SUMMARY OBJECTIVE To study the profile of associated autoimmune diseases in a series of patients with systemic lupus erythematosus (SLE) and see if such associations are linked to IgA deficiency. METHODS Two hundred eighty-one patients with SLE were studied for Ig A levels by nephelometry. Levels equal to or under 0.05g/dL were considered as IgA deficiency. Epidemiological and clinical data, including the presence of associated autoimmune diseases, were extracted from the patient’s charts. RESULTS Ig A deficiency was found in 6% of the patients. In 30.2% of SLE patients, there was at least one more autoimmune disease; Hashimoto thyroiditis and Sjögren’s syndrome were the most common. No association between the occurrence of associated autoimmune disease with IgA deficiency was found. CONCLUSIONS There is a high prevalence of autoimmune diseases associated with SLE. IgA deficiency does not affect the presence of these associations.


2017 ◽  
Vol 8 (1) ◽  
pp. 31-34 ◽  
Author(s):  
Meghan Romba ◽  
Yujie Wang ◽  
Shu-Ching Hu ◽  
Sandeep Khot

Dystonia as a manifestation of neuropsychiatric lupus erythematosus (NPSLE) is uncommon. We report a 25-year-old woman who experienced progressive confusion, reduced speech, and difficulty opening her mouth approximately 2 weeks after development of a facial rash. Brain imaging showed bilateral, symmetric signal abnormalities within the basal ganglia and subcortical white matter. Despite treatment with high-dose steroids, she continued to have difficulty speaking with evidence of jaw dystonia on examination. Jaw dystonia rapidly improved with the initiation of levodopa. Repeat evaluation 3 months later exhibited the absence of jaw dystonia and near resolution of the imaging abnormalities. Our patient demonstrated a unique presentation with jaw dystonia refractory to traditional treatment for NPSLE. Such a presentation likely represents a severe variant of NPSLE requiring both immunosuppressive and symptomatic therapies.


Sign in / Sign up

Export Citation Format

Share Document